Surgery Partners, Inc. reaffirmed earnings guidance for the fiscal year ended December 31, 2021. For the period, the company expects revenue of 19% to 21% growth over 2020 results.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.48 USD | -4.34% | -0.79% | -19.58% |
05-07 | Sector Update: Health Care Stocks Advance in Late Afternoon Trading | MT |
05-07 | Surgery Partners Rises after Q1 Adjusted Earnings, Revenue Increase; 2024 Revenue Outlook Boosted | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.58% | 3.37B | |
-24.78% | 15.28B | |
-1.80% | 11.88B | |
+3.15% | 11.61B | |
+8.80% | 10.63B | |
+26.29% | 8.6B | |
-8.00% | 7.37B | |
+5.79% | 6.8B | |
+9.84% | 6.53B | |
-4.42% | 4.36B |
- Stock Market
- Equities
- SGRY Stock
- News Surgery Partners, Inc.
- Surgery Partners, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ended December 31, 2021